Evidence supports the effectiveness of meditation in managing various common conditions. These apps can guide practice. If you’re hearing mindfulness and meditation more and...

Pfizer is now the COVID-19 vaccine of choice for some at-risk patients and those under 50 years of age in priority groups.

It’s no longer plain sailing in Australian community pharmacy. Bruce Annabel helps navigate in this, the fourth instalment of our Future Health series. Most...

Could selective serotonin reuptake inhibitors (SSRIs) help reduce the burden of Alzheimer’s disease and prevent decline from mild cognitive impairment? An estimated 10% of people...

When medication charting involves a pharmacist as well as a doctor, medication error rates in hospital admissions are significantly reduced, according to a new...

The PSA has opened Expressions of Interest (EOIs) for its first PSA Harm Reduction Champion, who will act as a national spokesperson.